T-Cells and Systemic Lupus Erythematosus

Systemic Lupus Erythematosus: A Companion to Rheumatology

Volumn , Issue , 2007, Pages 95-102

  Hoffman, Robert ^a,b   Maldonado, Marcos E ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952988361     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04434-9.50015-4     Document Type: Chapter

References (73)

1. Horowitz DA, Stohl W, Gray JD T lymphocytes, natural killer cells, cytokines, and immune regulation. Dubois' Lupus Erythematosus 1997, 155-194. Williams & Wilkins, Baltimore, Maryland. D.J. Wallace, B.H. Hahn (Eds.).
2. Tsokos GC, Boumpas DT Systemic lupus erythematosus. Molecular Pathology of Autoimmunity 2001, 255-281. Harwood Academic Publishers, New York. A. Theofilopoulos, C. Bona (Eds.).
3. Tsokos GC Overview of cellular immune function in systemic lupus erythematosus. Systemic Lupus Erythematosus, Fourth Edition 2004, 29-92. Academic Press, New York. R.G. Lahita (Ed.).
4. Hoffman RW T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol 2005, 113:4-13.
5. Klinman DM, Mushinski JF, Honda M, Ishigatsubo Y, Mountz JD, Raveche ES, et al. Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J Exp Med 1986, 163:1292-1307.
6. Holbrook MR, Tighe PJ, Powell RJ Restriction of T cell receptor beta chain repertoire in the peripheral blood of patients with systemic lupus erythematosus. Ann Rheum Dis 1996, 55:627-631.
7. Murata H, Matsumura R, Koyama A, Sugiyama T, Sueishi M, Shibuya K, et al. T cell receptor repertoire of T cells in the kidneys of patients with lupus nephritis. Arthritis Rheum 2002, 46:2141-2147.
8. Sharp GC, Hoffman RW Mixed connective tissue disease. Connective Tissue Diseases 1995, Chapman and Hall, London. J. Belch, R. Zurier (Eds.).
9. Reville JD Major histocompatibility complex class II and non-major histocompatibility genes in the pathogenesis of systemic lupus erythematosus. Systemic Lupus Erythematosus, Fourth Edition 2004, 109-115. Academic Press, New York. R.G. Lahita (Ed.).
10. Hoffman RW, Takeda Y, Sharp GC, Lee DR, Kaneoka K, Caldwell CW Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J Immunol 1993, 151:6460-6469.
11. Fenning S, Wolff-Vorbeck G, Hackl W, Krawinkel U, Luhrmann R, Northemann W, et al. T cell lines recognizing the 70kD protein of U1 small nuclear ribonucleoprotein (U1snRNP). Clin Exp Immunol 1995, 101:408-413.
12. Wolff-Vorbeck G, Hackl W, Fenning S, Krawinkel U, Luhrmann R, Peter HH Characterization of an HLA-DR4-restricted T cell clone recognizing a protein moiety of small nuclear ribonucleoproteins (UsnRNP). Clin Exp Immunol 1994, 95:378-384.
13. Goldrath AW, Bevan MJ Selecting and maintaining a diverse T-cell repertoire. Nature 1999, 402:255-262.
14. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity?. J Exp Med 1995, 181:1945-1948.
15. Sercarz EE, Lehmann PV, Amentani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Ann Rev Immunol 1993, 11:729-766.
16. Dighiero G, Rose NR Critical self-epitopes are key to understanding of self-tolerance and autoimmunity. Immunol Today 1999, 20:423-428.
17. Rajagopalan S, Zordan T, Tsokos GC, Datta SK Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: Isolation of CD4-8-T helper cell lines that express the gamma delta T-cell antigen receptor. Proc Natl Acad Sci USA 1990, 87:7020-7024.
18. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1994, 95:531-541.
19. Lu L, Kaliyaperumual A, Boumpas DT, Datta SK Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J Clin Invest 1999, 104:345-355.
20. O'Brien RM, Cram DS, Coppel RL, Harrison LC T-cell epitopes on the 70-kDa protein of the (U1)RNP complex in autoimmune rheumatologic disorders. J Autoimmunity 1990, 3:747-757.
21. Okubo M, Yammamoto K, Kato T, Matsuura N, Nishimaki T, Kasukawa R, et al. Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients. J Immunol 1993, 151:1108-1115.
22. Takeno M, Nagafuchi H, Kaneko S, Wakisaka S, Oneda K, Takeba T, et al. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J Immunol 1997, 158:3529-3538.
23. Holyst MM, Hill DL, Hoch SO, Hoffman RW Analysis of human T cell and B cell responses againgst U-small nuclear ribonucleoprotein 70kD, B, and D polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum 1997, 40:1493-1503.
24. Talken BL, Holyst MM, Hill DL, Hoffman RW T cell receptor beta-chain third complementary-determining region gene usage is highly restricted among Sm-B autoantigen-specific human T cell clones derived from patients with connective tissue disease. Arthritis Rheum 1999, 42:703-709.
25. Talken BL, Lee DR, Caldwell CW, Quinn TP, Schafermeyer KR, Hoffman RW Analysis of T cell receptors specific for U1-70kD small nuclear ribonucleoprotein autoantigen: The alpha chain complementary determining region three is highly conserved among connective tissue disease patients. Human Immunol 1999, 60:200-208.
26. Hoffman RW, Kaneoka H, Hsu KC, Takeda Y, Caldwell CW, Sharp GC Molecular analysis of the human immune response to the U1-70kD antigen. Mol Biol Rep 1991, 15:132.
27. Talken BL, Schafermeyer KR, Bailey CW, Lee DR, Hoffman RW T cell epitope mapping of the Sm autoantigen reveals that highly conserved Sm motifs are the dominant target of T cell immunity in systemic lupus erythematosus. J Immunol 2001, 167:562-568.
28. Talken BL, Bailey CW, Reardon SL, Caldwell CW, Hoffman RW Structural analysis of T cell receptor alpha and beta chains from human T cell clones specific for small nuclear ribonucleoprotein polypeptides Sm-D, Sm-B, and U1-70kD: TCR complementary determining region 3 usage appears highly conserved. Scand J Immunol 2001, 54:204-210.
29. Greidinger EL, Bailey CW, Schafermeyer KR, Reardon SL, Lee DR, Hoffman RW RNA binding domain is target of T cell immunity by U1-70kD specific human T cell clones. J Immunl 2002, 169:3429-3437.
30. De Silva-Udawatta M, Kumar SR, Greidinger EL, Hoffman RW Cloned human TCR from patients with autoimmune disease can respond to two structurally distinct autoantigens. J Immunol 2004, 172:3940-3947.
31. Greidinger EL, Gazitt T, Jaimes KF, Hoffman RW Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients provide help for autoantibody production. Arthritis Rheum 2004, 50:2216-2222.
32. Hoffman MH, Steiner G. Identification of hnRNP-A2 (A2/RA33) as a major B and T cell autoantigen in pristane-induced arthritis: Ninth International Workshop on Autoantibodies and Autoimmunity, Gainesville. 2005 (abstract).
33. Zieve GW, Khusial PR The anti-Sm immune response in autoimmunity and cell biology. Autoimmun Rev 2003, 2:235-240.
34. Fury MG, Zang W, Christodoulopoulos I, Zieve GW Multiple protein-protein interactions between the snRNP common core proteins. Exp Cell Res 1997, 1:63-69.
35. Krishnan S, Farber DL, Tsokos GC T cell rewiring in differentiation and disease. J Immunol 2003, 171:3325-3331.
36. Solomou EE, Juang YT, Gourley MF, Kammer GM, Tsokos GC Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J Immunol 2001, 166:4216-4222.
37. Herndon TM, Juang YT, Solomou EE, Rothwell SW, Gourley MF, Tsokos GC Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clin Immunol 2002, 103:145-153.
38. Tenbrock K, Juang YT, Gourley MF, Nambiar MP, Tsokos GC Antisense cyclic adenosine 5'-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J Immunol 2002, 169:4147-4152.
39. Kyttaris VC, Juang YT, Tenbrock K, Weinstein A, Tsokos GC Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus. J Immunol 2004, 173:3557-3563.
40. Elliott MR, Shanks RA, Khan IU, Brooks JW, Burkett PJ, Nelson BJ, et al. Kammer, Down-regulation of IL-2 production in T lymphocytes by phosphorylated protein kinase A-RIIbeta. J Immunol 2004, 172:7804-7812.
41. Krishnan S, Nambiar MP, Warke VG, Fisher CU, Mitchell J, Delaney N, et al. Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J Immunol 2004, 172:7821-7831.
42. Kammer GM Deficient protein kinase a in systemic lupus erythematosus: A disorder of T lymphocyte signal transduction. Ann NY Acad Sci 2002, 968:96-105.
43. Elliott MR, Tolnay M, Tsokos GC, Kammer GM Protein kinase A regulatory subunit type II beta directly interacts with and suppresses CREB transcriptional activity in activated T cells. J Immunol 2003, 171:3636-3644.
44. Cedeno S, Cifarelli DF, Blasini AM, Paris M, Placeres F, Alonso G, et al. Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: Potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin Immunol 2003, 106:41-49.
45. Xu L, Zhang L, Yi Y, Kang HK, Datta SK Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat Med 2004, 10:411-415.
46. Matzinger P. The danger model: A renewed sense of self. Science 2002, 296:301-305.
47. Nagy G, Barcza M, Gonchoroff N, Phillips PE, Perl A. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells. J Immunol 2004, 173:3676-3683.
48. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998, 41:1241-1250.
49. Janeway CA, Medzhitov R. Innate immune recognition. Ann Rev Immunol 2002, 20:197-216.
50. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik M, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002, 416:595-598.
51. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive T cells by CpG dsDNA. Immunity 2003, 19:837-847.
52. Hoffman RW, Gazitt T, Foecking MF, Ortmann RA, Misfeldt M, Jorgenson R, et al. U1-RNA induced innate immunity signaling. Arthritis Rheum 2004, 50:2891-2896.
53. Greidinger EL, Foecking MF, Ranatunga S, Hoffman RW Apoptotic U1-70kD is antigenically distinct from the intact form of the U1-70kD molecule. Arthritis Rheum 2002, 45:1264-1269.
54. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005, 52:1491-1503.
55. Zhuang H, Narain S, Sobel E, Lee PY, Nacionales DC, Kelly KM, et al. Assiociation of anti-nucleoprotein autoantibodies with upregulation of Type 1 interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus. Clin Immunol 2005 (Epub ahead of print).
56. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apototic keratinocytes. J Exp Med 1994, 179:1317-1330.
57. Andrade F, Casciola-Rosen L, Rosen A. Apoptosis in systemic lupus erythematosus: Clinical implications. Rheum Dis Clin North Am 2000, 26:215-227.
58. Walport MJ Complement and systemic lupus erythematosus. Arthritis Res 2002, 4:S279-S293.
59. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996, 97:2063-2071.
60. Yi Y, McNuerney M, Datta SK Regulatory defects, in Cb1 and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J Immunol 2000, 165:6627-6634.
61. Vakkalanka RK, Woo C, Kirou KA, Koshy M, Berger D, Crow MK Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum 1999, 42:871-881.
62. Crow MK, Kirou KA Regulation of CD40 ligand expression in systemic lupus erythematosus. Curr Opin Rheumatol 2001, 13:361-369.
63. Lu Q, Wu A, Richardson BC Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus inducing drugs. J Immunol 2005, 174:6212-6219.
64. Richardson BC, Powers D, Hooper F, Yung RL, Rourke KO Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum 1994, 37:1363-1372.
65. Yang J, Deng C, Hemati N, Hanash S, Richardson BC Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. J Immunol 1997, 159:1303-1309.
66. Kammer GM, Perl A, Richardson BC, Tsokos GC Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum 2002, 46:1139-1154.
67. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002, 32:666-669.
68. Shevach EM Regulatory T cells in autoimmunity. Ann Rev Immunol 2000, 18:432-449.
69. Powrie F, Maloy KJ Regulating the regulators. Science 2003, 299:1030-1031.
70. Shevach EM Regulatory/Suppressor T Cells in health and disease. Arthritis Rheum 2004, 50:2721-2724.
71. Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003, 21:273-276.
72. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC TCT stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005, 115:2904-2913.
73. Chen Z, Benoist C, Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci 2005, 102:14735-14740.